A nurse is caring for a client who is receiving parenteral nutrition and identifies that the client has hypoglycemia. Which of the following actions should the nurse take?

A) Ask another nurse if they are aware of potential interactions: Relying solely on another nurse's awareness of potential interactions is’not a comprehensive or reliable approach. Nurses may have varying levels of knowledge about medication interactions, and it's important to consult verified sources ’or accurate information.

B) Check the client's medical record for medication and food’interactions: While the client's medical record may contain information’about their current medications, it may not provide detailed information about potential interactions with specific foods or other medications. Additionally, relying solely on the medical record may not capture recent changes in medication or dietary intake.

C) Consult a drug reference guide for possible interactions: This is the correct action. Drug reference guides provide comprehensive information about medications, including potential interactions with other drugs and food. Nurses can access reliable drug reference guides to ensure they have accurate information before administering medications.

D) Have the client take the medication on an empty stomach to avoid interactions: Instructing the client to take medication on an empty stomach without knowledge of specific interactions could be inappropriate and potentially harmful. Some medications require administration with food to enhance absorption or reduce gastrointestinal side effects. It's essential to consult reliable sources ’o determine the appropriate administration instructions for each medication.

B) Nalbuphine: Nalbuphine is an opioid analgesic that acts on the central nervous system to relieve pain. When administered concurrently with morphine, there is a risk of additive respiratory depression and other opioid-related side effects, such as sedation and hypotension. Therefore, the nurse should clarify the prescription for nalbuphine with the provider to ensure that the combination of opioid medications is appropriate for the client's pain management. Additionally, nalbuphine has mixed agonist-antagonist properties and can precipitate withdrawal symptoms in clients who are physically dependent on full opioid agonists like morphine. Due to these potential interactions and safety concerns, it is essential for the nurse to obtain clarification from the provider before administering nalbuphine to the client receiving morphine via a PCA pump.

A) Ondansetron: Ondansetron is an antiemetic medication commonly prescribed to manage nausea and vomiting, which can be side effects of opioid analgesics like morphine. There are no significant contraindications or interactions between ondansetron and morphine, making it a suitable choice for adjunctive therapy in clients receiving PCA morphine for cancer pain.

C) Insulin glargine: Insulin glargine is a long-acting insulin analog used to control blood glucose levels in clients with diabetes mellitus. While clients with cancer may have comorbidities such as diabetes, the prescription for insulin glargine is unlikely to require clarification in the context of concurrent morphine use. However, the nurse should verify the client's current blood glucose levels and adjust the insulin dosage as needed based on the client's glycemic control.

D) Acetaminophen: Acetaminophen is a non-opioid analgesic commonly used to manage mild to moderate pain. When used in combination with opioids like morphine, acetaminophen can provide additive pain relief and may reduce the total opioid dosage required. There are no significant contraindications or interactions between acetaminophen and morphine, making it a suitable choice for adjunctive pain management in clients receiving PCA morphine for cancer pain.